AbbVie Inc. EPS (Diluted) 2011-2025 | ABBV
Beta
What is eps (diluted)?
Diluted earnings per share (EPS) can be defined as net income divided by the total number of shares outstanding including all dilutive securities such as stock options, warrants, and convertible bonds.
What is AbbVie Inc.'s current eps (diluted)?
AbbVie Inc. (ABBV) annual eps (diluted) for 2024 was $2.39, a 12.13% decline from 2023. AbbVie Inc. eps (diluted) for the quarter ending September 30, 2025 was $0.10.
What was AbbVie Inc.'s eps (diluted) in 2023?
AbbVie Inc. annual eps (diluted) for 2023 was $2.72, a 58.97% decline from 2022.
What was AbbVie Inc.'s eps (diluted) in 2022?
AbbVie Inc. annual eps (diluted) for 2022 was $6.63, a 2.79% increase from 2021.
What is AbbVie Inc.'s 5-year eps (diluted) CAGR?
AbbVie Inc. eps (diluted) grew at a compound annual growth rate (CAGR) of 14.66% from FY2019 to FY2024, going from $5.28 to $2.39 over 5 years.
EPS (Diluted) History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Declining
CAGR-14.7%
FY2019
$5.28
→
FY2024
$2.39
1112131415161718192021222324
5 years selected
EPS (Diluted) History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2024 | $2.39 | -12.1% | 10-K |
| FY2023 | $2.72 | -59.0% | 10-K |
| FY2022 | $6.63 | +2.8% | 10-K |
| FY2021 | $6.45 | +137.1% | 10-K |
| FY2020 | $2.72 | -48.5% | 10-K |
| FY2019 | $5.28 | +44.3% | 10-K |
| FY2018 | $3.66 | +10.9% | 10-K |
| FY2017 | $3.30 | -9.1% | 10-K |
| FY2016 | $3.63 | +16.0% | 10-K |
| FY2015 | $3.13 | +184.5% | 10-K |
| FY2014 | $1.10 | -57.0% | 10-K |
| FY2013 | $2.56 | -23.6% | 10-K |
| FY2012 | $3.35 | +53.7% | 10-K |
| FY2011 | $2.18 | - | 10-K |
Company: AbbVie Inc.Ticker: ABBVSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →